ALSTODT LANCE has filed 5 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 15625 shares of BioRestorative Therapies, Inc. ($BRTX) on October 06, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 6, 2025 | BioRestorative Therapies, Inc. | $BRTX | ALSTODT LANCE | President, CEO, COB | A | Common Stock | 15625 | $1.60 | 187,497.0000 | 9,116,172 | 9.09% | 0.17% |
| Oct. 6, 2025 | BioRestorative Therapies, Inc. | $BRTX | ALSTODT LANCE | President, CEO, COB | A | Warrant | 11719 | $0.00 | 11,719.0000 | 9,116,172 | 9999.99% | 0.13% |
| Feb. 14, 2025 | BioRestorative Therapies, Inc. | $BRTX | ALSTODT LANCE | President, CEO, COB | A | Stock Option | 791885 | $0.00 | 1,672,781.0000 | 7,763,932 | 89.90% | 10.20% |
| March 18, 2024 | BioRestorative Therapies, Inc. | $BRTX | ALSTODT LANCE | President, CEO, COB | F | Common Stock | 17633 | $1.39 | 171,872.0000 | 4,218,347 | 9.30% | 0.42% |
| Feb. 13, 2024 | BioRestorative Therapies, Inc. | $BRTX | ALSTODT LANCE | President, CEO, COB | A | Stock Option | 438596 | $0.00 | 880,896.0000 | 4,218,347 | 99.16% | 10.40% |